QTTB logo

Q32 Bio (QTTB)

Profile

Full Name

Q32 Bio Inc.

Ticker Symbol

QTTB

Exchange

NASDAQ

Sector

Healthcare

Industry

Biotechnology

Country

United States

IPO

March 28, 2018

Indexes

Not included

Website

http://www.q32bio.com

Employees

42

Key Details

Price

$2.12(+14.59%)

Market cap

Last Dividend

-

TTM Dividend yield

-

Annual revenue

-

Annual EPS

-$6.58(-46.06% YoY)

PE ratio

-

Next earnings date

May 30, 2025

Next ex-dividend date

N/A

Next split date

N/A

Price

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Current Price

$2.12
QTTB price is $2.12

30-Day Relative Volume

0.63
QTTB 30-day relative volume is 0.63

Price Performance

Price Most recent change

+14.59%
QTTB price was up +14.59% on Apr 17, 2025

Price YTD change

-38.37%
QTTB price is down -38.37% since January 1st

Price 1-year change

-91.21%
QTTB price is down -91.21% year-on-year

Price 3-year change

-94.39%
QTTB price is down -94.39% over the past 3 years

Price Range

Price All-time high

$572.40
QTTB price is currently -99.63% below its historical high of $572.40

Price 3-year low

$1.38
QTTB price is currently +53.62% above its 3-year low

Capitalization

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Market cap

Market cap

$25.86M
QTTB market capitalization is $25.86 million

Market cap 3-year change

-
QTTB market capitalization 3-year change is unknown

Market cap All-time high

$614.11M
QTTB market capitalization is currently -95.79% below its historical high of $614.11 million

Market cap sector rank

29.63%
QTTB market capitalization is higher than 29.63% of companies in Healthcare sector

Shares Outstanding

Shares Outstanding 1-Year Change

+2.25%
QTTB shares outstanding is up +2.25% year-on-year

Shares Outstanding 3-Year Change

-
QTTB shares outstanding 3-year change is unknown

Technical Indicators

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Beta

0.83
QTTB beta is 0.83

200-day SMA

$22.69
QTTB price is currently -90.66% below its 200-day simple moving average

50-day SMA

$2.16
QTTB price is currently -1.66% below its 50-day simple moving average

RSI

53.98
QTTB 14-day relative strength index is 53.98

Volume

0.63
QTTB 30-day relative volume is 0.63

ATR

$0.26
QTTB average true range is $0.26

10-day Historical Volatility

180.83%
QTTB 10-day historical volatility is 180.83%

Dividend

Income Statement

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Revenue

Revenue

-
QTTB annual revenue value is unknown

Revenue Analysts estimate

-
QTTB annual revenue consensus analysts' forecast is unknown

Revenue 1-year change

-
QTTB annual revenue 1-year change is unknown

Revenue Sector rank

-
QTTB annual revenue is unknown

EPS

EPS

-$6.58
QTTB annual earnings per share is -$6.58

EPS Analysts estimate

-$5.64
QTTB annual earnings per share is currently +16.73% higher than the consensus analysts' forecast

EPS 1-year change

-46.06%
QTTB annual earnings per share is down -46.06% year-on-year

EPS Sector rank

15.66%
QTTB annual earnings per share is higher than 15.66% of companies in Healthcare sector

Profit

Gross profit

-
QTTB annual gross profit value is unknown

Gross margin

-
QTTB annual gross profit margin value is unknown

Operating profit

-$66.10M
QTTB annual operating income is -$66.10 million

Operating margin

-
QTTB annual operating profit margin value is unknown

Net income

-$47.73M
QTTB annual net profit is -$47.73 million

Net margin

-
QTTB annual net profit margin value is unknown

Expenses

Total expenses

$66.10M
QTTB annual total expenses is $66.10 million

Operating expenses

$66.10M
QTTB annual total operating expenses is $66.10 million

Cost of goods sold

-
QTTB annual cost of goods sold value is unknown

Selling, general & administrative expenses

$17.96M
QTTB annual SGA is $17.96 million

Depreciation and amortization

$487.00K
QTTB annual depreciation & amortization is $487.00 thousand

Interest expense

$1.10M
QTTB annual interest expense is $1.10 million

Income tax

$21.00K
QTTB annual income tax is $21.00 thousand

EBIT & EBITDA

EBIT

-$44.99M
QTTB annual earnings before interest & taxes is -$44.99 million

EBITDA

-$44.50M
QTTB annual EBITDA is -$44.50 million

Balance Sheet

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Assets

Total assets

$92.33M
QTTB annual total assets is $92.33 million

Non current assets

$10.46M
QTTB annual long term assets is $10.46 million

Current assets

$81.88M
QTTB annual total current assets is $81.88 million

Cash and cash equivalents

$77.97M
QTTB annual cash & cash equivalents is $77.97 million

Accounts receivable

-
QTTB annual accounts receivable value is unknown

Inventory

-
QTTB annual inventory value is unknown

Liabilities

Total liabilities

$86.66M
QTTB annual total liabilities is $86.66 million

Long term liabilities

$70.19M
QTTB annual total long term liabilities is $70.19 million

Current liabilities

$16.46M
QTTB annual total current liabilities is $16.46 million

Accounts payable

$2.99M
QTTB annual accounts payable is $2.99 million

Debt

Total debt

$18.90M
QTTB annual total debt is $18.90 million

Total debt 1-year change

-62.82%
QTTB annual total debt is down -62.82% year-on-year

Long term debt

$15.19M
QTTB annual long term debt is $15.19 million

Short term debt

$3.71M
QTTB annual short term debt is $3.71 million

Equity & Capital

Shareholders equity

$5.67M
QTTB annual stockholders equity is $5.67 million

Book value

$5.67M
QTTB annual book value is $5.67 million

Retained earnings

-$234.81M
QTTB annual retained earnings is -$234.81 million

Working capital

$65.41M
QTTB annual working capital is $65.41 million

Cash Flow Statement

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Cashflow Activities

Cash from operations

-$67.72M
QTTB annual cash flow from operations is -$67.72 million

Cash from operations 1-year change

-262.56%
QTTB annual cash flow from operations is down -262.56% year-on-year

Cash from investing

$19.93M
QTTB annual cash flow from investing activities is $19.93 million

Cash from investing 1-year change

+398600%
QTTB annual cash flow from investing activities is up +398600% year-on-year

Cash from financing

$95.14M
QTTB annual cash flow from financing activities is $95.14 million

Cash from financing 1-year change

+23333%
QTTB annual cash flow from financing activities is up +23333% year-on-year

CAPEX

CAPEX

-
QTTB annual capital expenditures value is unknown

CAPEX 1-year change

-
QTTB annual capital expenditures 1-year change is unknown

Free Cash Flow

Free cash flow

-$67.79M
QTTB annual free cash flow is -$67.79 million

Free cash flow 1-year change

-262.86%
QTTB annual free cash flow is down -262.86% year-on-year

Profitability Ratios

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Margins

Gross margin

-
QTTB annual gross profit margin value is unknown

Operating margin

-
QTTB annual operating profit margin value is unknown

Net margin

-
QTTB annual net profit margin value is unknown

ROA & ROE

ROA

-51.70%
QTTB annual return on assets is -51.70%

ROE

-841.11%
QTTB annual return on equity is -841.11%

Valuation

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

PE Ratio

PE ratio

-
QTTB price to earnings ratio value is unknown

PE ratio Sector rank

-
QTTB price to earnings ratio is unknown

PB Ratio

PB ratio

4.56
QTTB price to book ratio is 4.56

PB ratio Sector rank

82.03%
QTTB price to book ratio is higher than 82.03% of companies in Healthcare sector

PS Ratio

PS ratio

-
QTTB price to sales ratio value is unknown

PS ratio Sector rank

-
QTTB price to sales ratio is unknown

Enterprise value

Enterprise value

-$33.21M
QTTB enterprise value is -$33.21 million

Enterprise value Sector rank

2.4%
QTTB enterprise value is higher than 2.4% of companies in Healthcare sector

EV/EBITDA

EV/EBITDA

0.75
QTTB EV/EBITDA is 0.75

EV/EBITDA Sector rank

73.89%
QTTB EV/EBITDA is higher than 73.89% of companies in Healthcare sector

Financial Health

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Liquidity

Current ratio

4.97
QTTB annual current ratio is 4.97

Quick ratio

-
QTTB annual quick ratio value is unknown

Leverage

Debt to equity

3.33
QTTB annual debt to equity ratio is 3.33

Interest coverage ratio

-40.90
QTTB annual interest coverage ratio is -40.90

Risk & Stability

Piotroski F-Score

-
QTTB piotroski f-score value is unknown

Altman Z-Score

-
QTTB altman z-score value is unknown

Analyst ratings

Recent major analysts updates

Mar 12, 25 Wells Fargo
Equal-Weight
Feb 11, 25 Piper Sandler
Neutral
Feb 11, 25 BMO Capital
Market Perform
Dec 12, 24 Guggenheim
Neutral
Dec 12, 24 BMO Capital
Outperform
Dec 11, 24 Wells Fargo
Equal-Weight
Dec 11, 24 Raymond James
Outperform
Dec 11, 24 Piper Sandler
Overweight
Dec 11, 24 Oppenheimer
Outperform
Dec 11, 24 Leerink Partners
Market Perform

Institutional Ownership

Similar stocks

MLEC logo
Moolec Science SA (MLEC)
DARE logo
Dare Bioscience (DARE)
TPST logo
Tempest Therapeutics (TPST)
Aspire BioPharma (ASBP)
GBIO logo
Generation Bio Co (GBIO)
LSB logo
LakeShore Biopharma Co Ltd (LSB)
POCI logo
Precision Optics (POCI)
DOMH logo
Dominari Holdings (DOMH)
Adagio Medical Holdings (ADGM)
  • What is the ticker symbol for Q32 Bio?
  • Does Q32 Bio pay dividends?
  • What sector is Q32 Bio in?
  • What industry is Q32 Bio in?
  • What country is Q32 Bio based in?
  • When did Q32 Bio go public?
  • Is Q32 Bio in the S&P 500?
  • Is Q32 Bio in the NASDAQ 100?
  • Is Q32 Bio in the Dow Jones?
  • When was Q32 Bio's last earnings report?
  • When does Q32 Bio report earnings?
  • Should I buy Q32 Bio stock now?

What is the ticker symbol for Q32 Bio?

The ticker symbol for Q32 Bio is NASDAQ:QTTB

Does Q32 Bio pay dividends?

No, Q32 Bio does not pay dividends

What sector is Q32 Bio in?

Q32 Bio is in the Healthcare sector

What industry is Q32 Bio in?

Q32 Bio is in the Biotechnology industry

What country is Q32 Bio based in?

Q32 Bio is headquartered in United States

When did Q32 Bio go public?

Q32 Bio's initial public offering (IPO) was on March 28, 2018

Is Q32 Bio in the S&P 500?

No, Q32 Bio is not included in the S&P 500 index

Is Q32 Bio in the NASDAQ 100?

No, Q32 Bio is not included in the NASDAQ 100 index

Is Q32 Bio in the Dow Jones?

No, Q32 Bio is not included in the Dow Jones index

When was Q32 Bio's last earnings report?

Q32 Bio's most recent earnings report was on Mar 11, 2025

When does Q32 Bio report earnings?

The next expected earnings date for Q32 Bio is May 30, 2025

Should I buy Q32 Bio stock now?

As of today, analysts generally recommend a 'Buy' rating. However, it's important to do your own research and consider your financial situation before making any investment decisions
On this page